1.Ruiz M, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. American Journal of Respiratory and Critical Care Medicine 1999; 160: 397–405.
2.Stankovic C, Mahajan P, Asmar BI. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia. Current Infectious Disease Reports 2007; 9: 223–227.
3.Chickering HT, Park JH. Staphylococcus aureus pneumonia. New England Journal of Medicine 1919; 72: 617–626.
4.Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958; 2: 233–236.
5.Martin CM, et al. Asian influenza A in Boston, 1957–58. Archives of Internal Medicine 1959; 103: 532–542.
6.Bhat N, et al. Influenza-associated deaths among children in the United States, 2003–2004. New England Journal of Medicine 2005; 353: 2559–2567.
7.Finelli L, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122: 805–811.
8.Kallen AJ, et al. Characteristics of Staphylococcus aureus community-acquired pneumonia during the 2006–2007 influenza season. Clinical Infectious Diseases 2007; 45: 1655.
9.Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza – Louisiana and Georgia, December 2006–January2007. Morbidity and Mortality Weekly Report 2008; 25: 325–329.
10.Hageman JC, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerging Infectious Diseases 2006; 12: 894–899.
11.Gillet Y, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clinical Infectious Diseases 2007; 45: 315–321.
12.Kallen AJ, et al. Staphylococcus aureus community-acquired pneumonia during the 2006–07 influenza season. Annals of Emergency Medicine 2008; 53: 358–365.
13.Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases 2007; 44: S27–S72.
14.American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2005; 171: 388–416.
15.Louria DB, et al. Studies on influenza in the pandemic of 1957–1958. II. Pulmonary complications of influenza. Journal of Clinical Investigation 1959; 38: 213–265.
16.Schwarzmann SW, et al. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Archives of Internal Medicine 1971; 127: 1037–1041.
17.Fisher AM, et al. Staphylococcal pneumonia: a review of 21 cases in adults. New England Journal of Medicine 1958; 258: 919–928.
18.Francis JS, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentin leukocidin genes. Clinical Infectious Diseases 2005; 40: 100–107.
19.Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus – Minnesota and North Dakota, 1997–1999. Morbidity and Mortality Weekly Report 1999; 48: 707–710.
20.Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436–1444.
21.Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666–674.